The Steve Jackson Laboratory Website
Transformative discoveries in genome and cellular integrity


Back to All Events

CRISPR in Drug Discovery 2019: From Targets to Therapeutics, Oxford, UK

  • King's Centre Osney Mead Oxford, England, OX2 United Kingdom (map)

Genome Engineering, including Zinc-finger, TALEN and most recently CRISPR/Cas9, has become a powerful tool in the drug discovery pipeline. This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, target validation in developing advanced cellular and in vivo disease models, and the pioneering applications in therapeutic genome editing. A current perspective of the applications of these rapidly developing technologies with a focus on drug discovery applications will be the meeting’s focus.